Sweetch
PREdicts personal diabetes risk and drives long-term behavioral change
Sweetch has raised €6.2M across 3 funding rounds from 5 investors, most recently a Series A round in Dec 2018. Based in Tel Aviv, Israel; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.2M
€6,150,061
Funding rounds
3
Investors
5
distinct backers
Active since
2015-04
latest 2018-12
Funding by year
EUR raised per yearSweetch — funding by year — interactive chart.
Data table
| Sweetch — funding by year | |
|---|---|
| 2015 | €0 |
| 2016 | €3.1M |
| 2018 | €3.1M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-12 | Series A | €3.1M | OurCrowd | View deal → |
| 2016-04-01 | Series A | €3.1M | LionBird,Philips,Pontifax Funds | View deal → |
| 2015-04-01 | Seed | €0 | SEEDIL | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData